Covectra Strengthens Board of Directors with Two New Key Appointments
WESTBOROUGH, Mass., March 2, 2021 /PRNewswire/ -- Covectra, a leader in serialization and track & trace solutions, announced the appointment of Renaat Van den Hooff and Gary Miloscia to its Board of Directors, effective February 15, 2021.
"On behalf of the entire Board of Directors, it is a pleasure to welcome Renaat and Gary, two highly accomplished industry veterans, to our team," said Steve Wood, President and Chief Executive Officer of Covectra. "Their collective experience across a range of diverse strategic roles will be highly instrumental as we continue to advance our product development and build out our pipeline. I look forward to working with them and leveraging their unique expertise."
Mr. Van den Hooff brings to the Covectra Board of Directors over 35 years of global operating experience in the healthcare industry, with specific expertise in consumer pharmaceuticals, medical devices and supplies/services for the pharmaceutical industry. He held various senior leadership positions, as CEO and board member of Temptime Corporation and as President and CEO of a public startup healthcare company that developed and sold innovative wound care products. He had a 20-year career with Johnson & Johnson, serving the latter time there as President of the J&J-Merck consumer pharmaceuticals joint venture worldwide. Mr. Van den Hoof has also been involved for almost 20 years with the National Multiple Sclerosis Foundation where he has served on the Board of Trustees and chaired multiple strategic committees supporting the CEO. He holds a Bachelor's degree from VLEKHO and a Masters degree from the Vlerick School of Management at the University of Ghent, Belgium.
Mr. Gary Miloscia has over 22 years of experience in a number of management positions. He currently serves as CFO for Covectra ,where he is responsible for all strategic business and financial planning and analysis as well as marketing activities. Prior to joining Covectra, he held senior level positions at Fidelity Investments, Health Dialog and American Express. Mr. Miloscia holds a Bachelor of Science in Finance from Rutgers University and an MBA in Finance from the Indiana University Kelley School of Business.
About Covectra
Covectra provides complete serialization, track & trace, and authentication technologies to secure, trace and manage products across the entire supply chain, extending to the unit dose level. Transforming supply chains with end unit traceability from the packaging line to the cloud, we enable customers to ensure brand protection, product safety and supply chain integrity in the pharmaceutical, food & beverage, luxury goods, and tobacco industries. With over 3 billion serial numbers issued worldwide, Covectra helps to combat counterfeiting & product diversion and to facilitate product recalls. To learn more, visit us at www.covectra.com, or follow us on Twitter at @COVECTRA1 and LinkedIn.
FOR MEDIA INQUIRIES:
Laura MacSweeney
Red Javelin
339-221-0614
[email protected]
SOURCE Covectra
Share this article